Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Items 1-10 of 62

Page
per page
  1. NVP-BEP800
    A4064 NVP-BEP800
    Target: HSP90
    Summary: Oral Hsp90β inhibitor, novel, fully synthetic
  2. PF-04929113 (SNX-5422)
    A4065 PF-04929113 (SNX-5422)
    Target: HSP90
    Summary: Hsp90 inhibitor,potent and selective
      ≥23.85 mg/mL
  3. Deltarasin
    A3358 Deltarasin
    Target: Phosphodiesterases (PDEs)
    Summary: KRAS-PDEδ interaction inhibitor
      Soluble in DMSO
  4. INCB024360 analogue
    A3493 INCB024360 analogue
    Summary: potent and selective inhibitor of IDO1
      ≥13.55 mg/mL
  5. Evacetrapib (LY2484595)
    A4377 Evacetrapib (LY2484595)
    Target: CETP
    Summary: CETP inhibitor,potent and selective
      ≥32.1 mg/mL
  6. XL-888
    A4388 XL-888
     1 Citation
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.2 mg/mL
  7. AT13387
    A4056 AT13387
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; ≥13.25 mg/mL
  8. IPI-504 (Retaspimycin hydrochloride)
    A4061 IPI-504 (Retaspimycin hydrochloride)
     3 Citation
    Target: HSP90
    Summary: Hsp90 inhibitor,novel, potent,selective
      ≥26.1 mg/mL
  9. AUY922 (NVP-AUY922)
    A4057 AUY922 (NVP-AUY922)
     1 Citation
    Target: HSP90
    Summary: Potent Hsp90 inhibitor
      ≥23.27 mg/mL
  10. SNX-2112
    A4068 SNX-2112
     1 Citation
    Summary: Hsp90 inhibitor,ATP-competitve,potent and selective
      ≥23.05 mg/mL

Items 1-10 of 62

Page
per page
Shop By
Now Shopping by
  1. Category Metabolism Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Aminopeptidase 1 item
  2. Carbonic Anhydrase 3item
  3. CETP 2item
  4. CYP3A/CYP450 1 item
  5. Dehydrogenase 4item
  6. DGAT 1 item
  7. Dopamine β-hydroxylase 2item
  8. FAAH 1 item
  9. Factor Xa 1 item
  10. Ferroptosis 1 item
  11. HMG-CoA Reductase 5item
  12. HSP 9item
  13. IDO 3item
  14. KRAS-PDEδ 1 item
  15. Lipid Metabolism 1 item
  16. P450 3item
  17. PDE 12item
  18. Phospholipase 2item
  19. SCD 1 item
  20. SGLT 1 item
  21. Transferase 6item
  22. monooxygenase 1 item
Reversibility
  1. Reversible 1 item
  2. Irreversible 3item
Target
  1. Acyl coenzyme A: cholesterol acyltransferases 1 item
  2. Factor Xa 1 item
  3. Phosphodiesterases (PDEs) 10item
  4. 3-phosphoglycerate dehydrogenase 1 item
  5. Kynurenine-3-monooxygenase 1 item
  6. Aminopeptidases 1 item
  7. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  8. HSP90 7item
  9. Cytochrome P450 (CYP450) 3item
  10. Ferroptosis 1 item
  11. HMG-CoA Reductases 5item
  12. SGLT 1 item
  13. DGAT 2item
  14. CETP 2item
  15. Lactate Dehydrogenases (LDH) 2item
  16. Fatty-acid-binding proteins (FABPs) 1 item
  17. IDH2 1 item
  18. Nampt 1 item
  19. Carbonic Anhydrases 3item
  20. Aldehyde Dehydrogenases 1 item
  21. Phospholipases 1 item
  22. Catechol O-Methyltransferase (COMT) 1 item
  23. FPTase 1 item
  24. Ftase 1 item
  25. FAAH 1 item
  26. IDO 1 item
  27. Glycogen Phosphorylases 1 item
Reported Experiments
  1. Animal Experiments 58item
  2. Cell Experiments 42item
Related Disease
  1. Acne 1 item
  2. Acute Myelogenous Leukemia 1 item
  3. Acute Myeloid Leukemia 2item
  4. Bladder Carcinoma 1 item
  5. Brain Injuries Studies 1 item
  6. Breast Cancer 8item
  7. Cancer 25item
  8. Chronic Lymphocytic Leukemia 1 item
  9. Cocaine-Related Disorders 2item
  10. Colon Cancer 1 item
  11. Diabetes 2item
  12. Dyslipidemia 1 item
  13. Epilepsy 1 item
  14. Erectile Dysfunction 3item
  15. Glioblastoma 1 item
  16. Glioma 1 item
  17. Hepatic Cancer 1 item
  18. HIV Infections 1 item
  19. Hypercholesterolemia 2item
  20. Inflammation 1 item
  21. Inflammatory Diseases 1 item
  22. Leukemia 1 item
  23. Lung Cancer 3item
  24. Lymphoma 1 item
  25. Melanoma 7item
  26. Multiple Myeloma 2item
  27. Neuroblastoma 2item
  28. Neurocognitive Disorders 1 item
  29. Non-small Cell Lung Cancer 2item
  30. Obsessive-Compulsive Disorder 1 item
  31. Osteoporosis 1 item
  32. Pancreatic Cancer 2item
  33. Pancreatic Carcinoma 1 item
  34. Prostate Cancer 7item
  35. Psoriasis 2item
  36. Psoriasis Vulgaris 1 item
  37. Pulmonary Arterial Hypertension 1 item
  38. Rheumatoid Arthritis 1 item
  39. Schizophrenia 2item
  40. Type 2 Diabetes 2item